This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jin, Y. Articles by Cattini, P. A. Search for Related Content PubMed PubMed Citation Articles by Jin, Y. Articles by Cattini, P. A.

A Role for A/T-Rich Sequences and Pit-1/GHF-1 in a Distal Enhancer Located in the Human Growth Hormone Locus Control Region with Preferential Pituitary Activity in Culture and Transgenic Mice

Department of Physiology University of Manitoba Winnipeg, Manitoba, Canada, R3E 3J7

A region located remotely upstream of the human pituitary GH (GH-N) gene and required for efficient GH-N gene expression in the pituitary of transgenic mice was cloned as a 1.6-kb BglII (1.6G) fragment. The 1.6G fragment in the forward or reverse orientation increased -496GH-N promoter activity significantly in pituitary GC and GH3 cells after gene transfer. The 1.6G fragment was also able to stimulate activity from a minimal thymidine kinase (TK) promoter which, unlike -496GH-N, lacked any Pit-1/GHF-1 element. Enhancer activity was localized by deletion analysis to a 203-bp region in the 3'-end of the 1.6G fragment and was characterized by the presence of a diffuse 136-bp nuclease-protected site, observed with pituitary (GC) but not nonpituitary (HeLa) cell nuclear protein. A major low-mobility complex was observed by electrophoretic mobility shift assay (EMSA) with GC cell nuclear protein, and the pattern was distinct from that seen with a HeLa cell extract. The nuclease-protected region contains three A/T-rich Pit-1/GHF-1-like elements, and their disruption, in the context of the 203-bp region fused to the TK promoter, reduced enhancer activity significantly in pituitary cells in culture. A mutation in this region was also shown to decrease enhancer activity in transgenic mice and correlated with a decrease in the 203-bp enhancer region complex observed by EMSA. The participation of Pit-1/GHF-1 in this complex is indicated by competition studies with Pit-1/GHF-1 elements and antibodies, and direct binding of Pit-1/GHF-1 to the A/T-rich sequences was shown by EMSA using recombinant protein. These studies link the A/T-rich sequences to the distal enhancer activity associated with the GH locus control region in vitro and in vivo.

This article has been cited by other articles:

				M. Giordano, M. Godi, S. Mellone, A. Petri, D. Vivenza, L. Tiradani, Y. Carlomagno, D. Ferrante, T. Arrigo, G. Corneli, et al. A Functional Common Polymorphism in the Vitamin D-Responsive Element of the GH1 Promoter Contributes to Isolated Growth Hormone Deficiency J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 1005 - 1012. [Abstract] [Full Text] [PDF]

				M. A. Trujillo, M. Sakagashira, and N. L. Eberhardt The Human Growth Hormone Gene Contains a Silencer Embedded within an Alu Repeat in the 3'-Flanking Region Mol. Endocrinol., October 1, 2006; 20(10): 2559 - 2575. [Abstract] [Full Text] [PDF]

				L. D. Norquay, X. Yang, Y. Jin, K. A. Detillieux, and P. A. Cattini Hepatocyte Nuclear Factor-3{alpha} Binding at P Sequences of the Human Growth Hormone Locus Is Associated with Pituitary Repressor Function Mol. Endocrinol., March 1, 2006; 20(3): 598 - 607. [Abstract] [Full Text] [PDF]

				K Wagner, K Hemminki, E Israelsson, E Grzybowska, R Klaes, B Chen, D Butkiewicz, J Pamula, W Pekala, and A Forsti Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 917 - 928. [Abstract] [Full Text] [PDF]

				P. Su, J. C. Wu, J. R. Sommer, A. J. Gore, R. M. Petters, and W. L. Miller Conditional Induction of Ovulation in Mice Biol Reprod, October 1, 2005; 73(4): 681 - 687. [Abstract] [Full Text] [PDF]

				C. Roche, A. J Zamora, D. Taieb, E. Lavaque, R. Rasolonjanahary, H. Dufour, C. Bagnis, A. Enjalbert, and A. Barlier Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters J. Endocrinol., October 1, 2004; 183(1): 217 - 233. [Abstract] [Full Text] [PDF]

				Y. Jin, L. D. Norquay, X. Yang, S. Gregoire, and P. A. Cattini Binding of AP-2 and ETS-Domain Family Members Is Associated with Enhancer Activity in the Hypersensitive Site III Region of the Human Growth Hormone/Chorionic Somatomammotropin Locus Mol. Endocrinol., March 1, 2004; 18(3): 574 - 587. [Abstract] [Full Text] [PDF]

				L. D. Norquay, X. Yang, P. Sheppard, S. Gregoire, J. G. Dodd, W. Reith, and P. A. Cattini RFX1 and NF-1 Associate with P Sequences of the Human Growth Hormone Locus in Pituitary Chromatin Mol. Endocrinol., June 1, 2003; 17(6): 1027 - 1038. [Abstract] [Full Text] [PDF]

				A. J. Norris, J. A. Stirland, D. W. McFerran, Z. C. Seymour, D. G. Spiller, A. S. I. Loudon, M. R. H. White, and J. R. E. Davis Dynamic Patterns of Growth Hormone Gene Transcription in Individual Living Pituitary Cells Mol. Endocrinol., February 1, 2003; 17(2): 193 - 202. [Abstract] [Full Text] [PDF]

				B. L. Triggs-Raine, R. D. Kirkpatrick, S. L. Kelly, L. D. Norquay, P. A. Cattini, K. Yamagata, A. J. G. Hanley, B. Zinman, S. B. Harris, P. H. Barrett, et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community PNAS, April 2, 2002; 99(7): 4614 - 4619. [Abstract] [Full Text] [PDF]

				D. W. McFerran, J. A. Stirland, A. J. Norris, R. A. Khan, N. Takasuka, Z. C. Seymour, M. S. Gill, W. R. Robertson, A. S. I. Loudon, J. R. E. Davis, et al. Persistent Synchronized Oscillations in Prolactin Gene Promoter Activity in Living Pituitary Cells Endocrinology, July 1, 2001; 142(7): 3255 - 3260. [Abstract] [Full Text] [PDF]

				B. Andersen and M. G. Rosenfeld POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease Endocr. Rev., February 1, 2001; 22(1): 2 - 35. [Abstract] [Full Text]

				K. M. Scully, E. M. Jacobson, K. Jepsen, V. Lunyak, H. Viadiu, C. Carrière, D. W. Rose, F. Hooshmand, A. K. Aggarwal, and M. G. Rosenfeld Allosteric Effects of Pit-1 DNA Sites on Long-Term Repression in Cell Type Specification Science, November 10, 2000; 290(5494): 1127 - 1131. [Abstract] [Full Text]

				B. L. Triggs-Raine, R. D. Kirkpatrick, S. L. Kelly, L. D. Norquay, P. A. Cattini, K. Yamagata, A. J. G. Hanley, B. Zinman, S. B. Harris, P. H. Barrett, et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community PNAS, April 2, 2002; 99(7): 4614 - 4619. [Abstract] [Full Text] [PDF]